Interpretable RNA-Seq Clustering with an LLM-Based Agentic Evidence-Grounded Framework
Elias Hossain, Mehrdad Shoeibi, Ivan Garibay, Niloofar Yousefi
TL;DR
This work addresses the interpretive bottleneck in RNA-seq cluster analysis by focusing on finding concrete, literature-grounded explanations for gene modules rather than generic enrichment results. It introduces CITE V.1, an agentic LLM-based framework with Retriever, Interpreter, and Critics to ground RNA-seq cluster interpretations in PubMed and UniProt evidence. In comparative evaluations against a Gemini baseline, CITE V.1 provides structured, auditable interpretations with reliability flags and confidence scores, reducing speculative outputs and false citations. The approach enhances transparency and reproducibility in biomedical AI and offers a scalable foundation for evidence-grounded analyses across pathogens.
Abstract
We propose CITE V.1, an agentic, evidence-grounded framework that leverages Large Language Models (LLMs) to provide transparent and reproducible interpretations of RNA-seq clusters. Unlike existing enrichment-based approaches that reduce results to broad statistical associations and LLM-only models that risk unsupported claims or fabricated citations, CITE V.1 transforms cluster interpretation by producing biologically coherent explanations explicitly anchored in the biomedical literature. The framework orchestrates three specialized agents: a Retriever that gathers domain knowledge from PubMed and UniProt, an Interpreter that formulates functional hypotheses, and Critics that evaluate claims, enforce evidence grounding, and qualify uncertainty through confidence and reliability indicators. Applied to Salmonella enterica RNA-seq data, CITE V.1 generated biologically meaningful insights supported by the literature, while an LLM-only Gemini baseline frequently produced speculative results with false citations. By moving RNA-seq analysis from surface-level enrichment to auditable, interpretable, and evidence-based hypothesis generation, CITE V.1 advances the transparency and reliability of AI in biomedicine.
